These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 35532073)
1. Anti-citrullinated protein antibody specificities and pulmonary fibrosis in relation to genetic loci in early rheumatoid arthritis. Brink M; Ljung L; Hansson M; Rönnelid J; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S Rheumatology (Oxford); 2022 Nov; 61(12):4985-4990. PubMed ID: 35532073 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary fibrosis in relation to genetic loci in an inception cohort of patients with early rheumatoid arthritis from northern Sweden. Jönsson E; Ljung L; Norrman E; Freyhult E; Ärlestig L; Dahlqvist J; Rantapää-Dahlqvist S Rheumatology (Oxford); 2022 Mar; 61(3):943-952. PubMed ID: 33993221 [TBL] [Abstract][Full Text] [Related]
3. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study. Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Rönnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S RMD Open; 2019; 5(2):e000946. PubMed ID: 31565241 [TBL] [Abstract][Full Text] [Related]
4. Differences in the Spectrum of Anti-Citrullinated Protein Antibody Fine Specificities Between Malaysian and Swedish Patients With Rheumatoid Arthritis: Implications for Disease Pathogenesis. Too CL; Murad S; Hansson M; Alm LM; Dhaliwal JS; Holmdahl R; Jakobsson PJ; Alfredsson L; Klareskog L; Rönnelid J; Padyukov L Arthritis Rheumatol; 2017 Jan; 69(1):58-69. PubMed ID: 27483449 [TBL] [Abstract][Full Text] [Related]
5. Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis. Joshua V; Hensvold AH; Reynisdottir G; Hansson M; Cornillet M; Nogueira L; Serre G; Nyren S; Karimi R; Eklund A; Sköld M; Grunewald J; Chatzidionysiou K; Catrina A RMD Open; 2020 Sep; 6(2):. PubMed ID: 32917833 [TBL] [Abstract][Full Text] [Related]
6. Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis. Cabrera-Villalba S; Gomara MJ; Cañete JD; Ramírez J; Salvador G; Ruiz-Esquide V; Hernández MV; Inciarte-Mundo J; Haro I; Sanmartí R Arthritis Res Ther; 2017 Jun; 19(1):141. PubMed ID: 28619044 [TBL] [Abstract][Full Text] [Related]
7. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis. Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G Front Immunol; 2018; 9():876. PubMed ID: 29740454 [TBL] [Abstract][Full Text] [Related]
8. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate. Hensvold AH; Joshua V; Li W; Larkin M; Qureshi F; Israelsson L; Padyukov L; Lundberg K; Defranoux N; Saevarsdottir S; Catrina AI Arthritis Res Ther; 2015 Sep; 17(1):239. PubMed ID: 26337028 [TBL] [Abstract][Full Text] [Related]
9. Association of Antibodies to Citrullinated Protein Antigens with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis. Hughes-Austin JM; Gan RW; Deane KD; Weisman MH; Demoruelle MK; Sokolove J; Robinson WH; Holers VM; Norris JM; Ix JH Am J Nephrol; 2017; 46(6):481-487. PubMed ID: 29237149 [TBL] [Abstract][Full Text] [Related]
10. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis. Sahlström P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsström B; Stålesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmström V; Grönwall C Arthritis Rheumatol; 2020 Oct; 72(10):1643-1657. PubMed ID: 32501655 [TBL] [Abstract][Full Text] [Related]
11. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells. Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052 [TBL] [Abstract][Full Text] [Related]
12. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy. Jonsson MK; Hensvold AH; Hansson M; Aga AB; Sexton J; Mathsson-Alm L; Cornillet M; Serre G; Lillegraven S; Fevang BS; Catrina AI; Haavardsholm EA Arthritis Res Ther; 2018 Jul; 20(1):146. PubMed ID: 30001740 [TBL] [Abstract][Full Text] [Related]
13. Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile. Lundberg K; Bengtsson C; Kharlamova N; Reed E; Jiang X; Kallberg H; Pollak-Dorocic I; Israelsson L; Kessel C; Padyukov L; Holmdahl R; Alfredsson L; Klareskog L Ann Rheum Dis; 2013 May; 72(5):652-8. PubMed ID: 22661643 [TBL] [Abstract][Full Text] [Related]
14. Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis. Manca ML; Alunno A; D'Amato C; Bistoni O; Puxeddu I; Gerli R; Migliorini P; Pratesi F Joint Bone Spine; 2018 Jul; 85(4):441-445. PubMed ID: 28826660 [TBL] [Abstract][Full Text] [Related]
15. Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease. Fisher BA; Bang SY; Chowdhury M; Lee HS; Kim JH; Charles P; Venables P; Bae SC Ann Rheum Dis; 2014 Apr; 73(4):741-7. PubMed ID: 23505239 [TBL] [Abstract][Full Text] [Related]
16. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting. van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716 [TBL] [Abstract][Full Text] [Related]
17. Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants. Rönnelid J; Hansson M; Mathsson-Alm L; Cornillet M; Reed E; Jakobsson PJ; Alfredsson L; Holmdahl R; Skriner K; Serre G; Lundberg K; Klareskog L Ann Rheum Dis; 2018 Feb; 77(2):203-211. PubMed ID: 29070529 [TBL] [Abstract][Full Text] [Related]
18. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Ding B; Padyukov L; Lundström E; Seielstad M; Plenge RM; Oksenberg JR; Gregersen PK; Alfredsson L; Klareskog L Arthritis Rheum; 2009 Jan; 60(1):30-8. PubMed ID: 19116921 [TBL] [Abstract][Full Text] [Related]
19. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens. Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients. Meyer P; Ally M; Hodkinson B; Anderson R; Tikly M Afr Health Sci; 2018 Jun; 18(2):295-303. PubMed ID: 30602956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]